ArticleActa pharmacologica Sinica2026

Antiemetic drug fosaprepitant exerts anti-tumor effects against NSCLC by targeting FAK to inhibit AKT and JNK/c-Jun pathways.

Ying Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.